Trial Information
Summary: Premature Infants
Children who were born prematurely are asked to participate in a
research study being conducted by Jacobi Medical Center.
Your infant may be eligible to participate in this study
if he/she:
- Is less than 6 months old
- Was born prematurely at 32-35 weeks
Your child may not participate in this study if
he/she:
- Has been treated with palivizumab or RSV-IGIV
- Is currently hospitalized
- Has confirmed prior or current infection with RSV
For more information,
|
Contact:
Cecilia Gutierrez, Study Coordinator
Biomedical Research Alliance of New York
Jacobi Medical Center
1400 Pelham Parkway South
Bronx, NY 10461
Telephone: 718-918-5348
Fax: 718-918-4308
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:46:23 AM